Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy.
Adult Refsum disease is characterized by an elevated plasma phytanic acid level and high concentrations of phytanic acid in a variety of tissues. Besides tapetoretinal degeneration, additional symptoms are anosmia, skeletal malformations, chronic polyneuropathy, cerebellar ataxia, sensorineural hearing loss, ichthyosis, and cardiac abnormalities. A diet low in phytanic acid ameliorates polyneuropathy and ataxia and slows or even stops the other manifestations. In order to be able to apply dietary therapy, as many patients as possible (even better if all of them are) have to be identified at an early stage. The ophthalmologist plays a crucial role in achieving this goal because of the early manifestation of the tapetoretinal degeneration.
Rüether
Klaus
K
Charité-Eye Hospital, Campus Virchow-Klinikum, Berlin, Germany. klaus.ruether@charite.de
Baldwin
Eleanor
E
Casteels
Minne
M
Feher
Michael D
MD
Horn
Morten
M
Kuranoff
Susan
S
Leroy
Bart P
BP
Wanders
Ronald J
RJ
Wierzbicki
Anthony S
AS
D000328:Adult; D006801:Humans; D010831:Phytanic Acid / Q000097:blood; D012035:Refsum Disease / Q000175:diagnosis / Q000628:therapy; D012174:Retinitis Pigmentosa / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
D010831:Phytanic Acid